Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 16, 2023
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
[ Tue, May 16th 2023
] - WOPRAI
Mon, May 15, 2023
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy and Held Target at $45 on, May 15th, 2023
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $45 on, May 15th, 2023.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Bradley
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Thursday, May 11th, 2023
- Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $50 on, Thursday, May 11th, 2023
